You are viewing the site in preview mode
Skip to main content
|
Consort item and number
|
Latin America (%)
|
Spain (%)
|
All (%)
|
|---|
|
Title & abstract
|
1a
|
Title
|
16
|
30
|
24
|
|
1b
|
Abstract
|
55
|
82
|
70
|
|
Methods
|
3a
|
Trial design
|
58
|
55
|
56
|
|
4a
|
Participants
|
72
|
82
|
78
|
|
4b
|
Settings
|
43
|
44
|
43
|
|
5
|
Interventions
|
88
|
84
|
86
|
|
6a
|
Outcomes
|
21
|
22
|
22
|
|
Randomisation
|
7a
|
Sample size
|
22
|
19
|
20
|
|
8a
|
Sequence generation
|
28
|
35
|
32
|
|
9
|
Allocation concealment
|
12
|
11
|
11
|
|
10
|
Implementation
|
3
|
0
|
1
|
|
11a
|
Blinding
|
24
|
18
|
21
|
|
12a
|
Statistical methods
|
44
|
37
|
40
|
|
Results
|
13a
|
Participant flow
|
35
|
28
|
31
|
|
13b
|
Losses & exclusions
|
20
|
19
|
19
|
|
14a
|
Dates of recruitment
|
5
|
4
|
4
|
|
15
|
Baseline data
|
29
|
39
|
34
|
|
16
|
Numbers analysed
|
15
|
15
|
15
|
|
17a
|
Outcomes & estimation
|
3
|
5
|
4
|
|
19
|
Harms
|
26
|
29
|
28
|
|
Other information
|
23
|
Registration
|
2
|
5
|
4
|
|
24
|
Protocol
|
0
|
1
|
1
|
|
25
|
Funding
|
28
|
25
|
26
|